TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma
Qinghong Li(Shanghai FRP Research Institute (China)), Hongyuan Liang(Shanghai FRP Research Institute (China)), Aidong Qu(Shanghai FRP Research Institute (China)), Jingyi Xu(First Hospital of China Medical University), Wenyan Shen(Lanzhou University), Kunming Zhang(Shanghai FRP Research Institute (China)), Zeng Yu(Shanghai FRP Research Institute (China)), Yu Yao(Qinghai University)
Cited by 0
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227
Adult IDH wild-type lower-grade gliomas should be further stratified
|Neuro-Oncology|2017|222